Together we will beat cancer


Breast cancer is the most common cancer in the UK, with around 55,200 people diagnosed each year. It starts in the breast tissue, most commonly in cells lining the milk ducts. Breast cancer predominantly affects women, but men can get it too.

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Usually located in Chicago, researchers and clinicians around the world met virtually this year to present the latest in cancer research at the American Society of Clinical Oncology (ASCO) annual meeting. Here’s a flavour of the some of the top research presented.

Read More

‘Will cancer make me infertile?’ – That Cancer Conversation

This entry is part 1 of 1 in the series That Cancer Conversation

For the first episode of our new podcast, we explore cancer and infertility.

Read More

Predicting future breast cancer with precision

This entry is part 26 of 26 in the series Cancer Grand Challenges

An international team of Cancer Grand Challenges scientists are conducting one biggest studies of its kind to try to predict who will develop invasive breast cancer.

Read More

Changes detected in BRCA1 breast cells before they turn cancerous

Scientists have mapped out some of the earliest changes that occur in seemingly healthy breast tissue long before any tumours appear.

Read More

Paying it forward: When Maria met Sheeba

On International Women’s Day, we share the inspiring story of one of our clinician scientists and the philanthropist who supports her work.

Read More

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

Read More

Four new cancer drugs approved on NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

Read More

Cancer blood test uses ‘noise cancellation’ to improve sensitivity

Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.

Read More

Immunotherapy for triple negative breast cancer approved for NHS in England 

Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer.

Read More

Zooming in on breast cancer reveals how mutations shape the tumour landscape

Scientists have created one of the most detailed maps of breast cancer ever achieved, revealing how genetic changes shape the physical tumour landscape.

Read More